Complications of orbital implants: A review of 542 patients who have undergone orbital implantation and 275 subsequent peg placements

Orbit

Volumn 26, Issue 3, 2007, Pages 173-182

  Shoamanesh, Ashkan ^a,c   Pang, Noelene K ^b   Oestreicher, James H ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

Anophthalmia; Implant complications; Orbital implants; Pegging; Silicone implants; Titanium pegs

Indexed keywords

PLASTIC; SILICON; TITANIUM;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; ENUCLEATION; EVISCERATION; FEMALE; FOLLOW UP; HUMAN; IMPLANT; MALE; MEDICAL RECORD; ORBIT IMPLANT; PYOGENIC GRANULOMA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; CHILD; DURAPATITE; EYE ENUCLEATION; EYE EVISCERATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; ORBIT; ORBITAL IMPLANTS; POLYETHYLENES; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; SILICONES;

EID: 34648832884     PISSN: 01676830     EISSN: 17445108     Source Type: Journal    
DOI: 10.1080/01676830701555204     Document Type: Conference Paper

References (32)

1. Ashworth JL, et al. The hydroxyapatite orbital implant: a prospective study. Eye. 1996;10:29-37.
2. Ashworth JL, et al. A clinical study of the hydroxyapatite orbital implant. Eur J Ophthalmol. 1997;7:1-8.
3. Blaydon SM, et al. The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases. Ophthal Plast Reconstr Surg. 2003;19:364-371.
4. Chen YH, Cui HG. High density porous polyethylene material (Medpor) as an unwrapped orbital implant. J Zhejiang Univ Sci B. 2006;7:679-682.
5. Cheng MS, et al. Late porous polyethylene implant exposure after motility coupling post placement. Am J Ophthalmol. 2004;138:420-424.
6. Christmas NJ, et al. Intraorbital implants after enucleation and their complications: a 10-year review. Arch Ophthalmol. 1998;116:1199-1203.
7. Edelstein C, et al. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology. 1998;105:1128-1129.
8. Fong KS, Choo CT. Hydroxyapatite orbital implants - our local experience. Ann Acad Med Singapore. 1997;26:405-408.
9. Georgiadis NS, et al. Coralline hydroxyapatite sphere in orbit restoration. Eur J Ophthalmol. 1999;9:302-308.
10. Jordan DR. Spontaneous loosening of hydroxyapatite peg sleeves. Ophthalmology. 2001;108:2041-2044.
11. Jordan DR. Problems after evisceration surgery with porous orbital implants: experience with 86 patients. Ophthal Plast Reconstr Surg. 2004;20:374-380.
12. Jordan DR, Bawazeer A. Experience with 120 synthetic hydroxyapatite implants (FCI3). Ophthal Plast Reconstr Surg. 2001;17:184-190.
13. Jordan DR, Klapper SR. A new titanium peg system for hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg. 2000;16:380-387.
14. Jordan DR, et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology. 1999;106:505-512.
15. Jordan DR, et al. The bioceramic orbital implant: experience with 107 implants. Ophthal Plast Reconstr Surg. 2003a;19:128-135.
16. Jordan DR, et al. The use of vicryl mesh in 200 porous orbital implants: a technique with few exposures. Ophthal Plast Reconstr Surg. 2003b;19:53-61.
17. Jordan DR, et al. Coralline hydroxyapatite orbital implant (bio-eye): experience with 158 patients. Ophthal Plast Reconstr Surg. 2004;20:69-74.
18. Lee SY, et al. Complications in motility peg placement for hydroxyapatite orbital implant in anophthalmic socket. Jpn J Ophthalmol. 2002;46:103-107.
19. Lin CJ, et al. Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol. 2002;86:394-396.
20. Mules PH. Evisceration of the globe, with artificial vitreous. Trans Ophthalmol Soc UK. 1885;5:200-2006.
21. Norda AG, Meyer-Rusenberg HW. Experience with orbital implants in particular with porous hydroxyapatite materials. Ophthalmologe. 2003;100:435-436.
22. Oestreicher JH. Treatment of exposed Coral implant after failed scleral patch graft. Ophthal Plast Reconstr Surg. 1994;10:110-113.
23. Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxyapatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology. 1997;104:324-329.
24. Perry AC. Advances in enucleation. Ophthal Plast Reconstr Surg. 1991;4:173-182.
25. Rosner B. Fundamentals of Biostatistics, 6th ed.. Toronto: Duxbury Press, 2006.chapter 10.6
26. Sarvananthan N, et al. Synthetic hydroxyapatite orbital implants: a clinical and MRI evaluation. Eye. 1999;13:205-208.
27. Shields CL, et al. Hydroxyapatite orbital implant after enucleation. Experience with initial 100 consecutive cases. Arch Ophthalmol. 1992;110:333-338.
28. Shields CL, et al. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc. 1993a;91:177-189.
29. Shields JA, et al. Hydroxyapatite orbital implant after enucleation - experience with 200 cases. Mayo Clin Proc. 1993b;68:1191-1195.
30. Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconstr Surg. 2004;20:274-280.
31. Suter AJ, et al. Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol. 2002;86:1287-1292.
32. Trichopoulos N, Augsburger JJ. Enucleation with unwrapped porous and nonporous orbital implants: a 15-year experience. Ophthal Plast Reconstr Surg. 2005;21:331-336.